DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

LinksClose Window

References

Francis P, Singer C, Saunders C. et al.
BRCA-P: An international randomised phase III study evaluating the RANK ligand inhibitor denosumab for the prevention of breast cancer in BRCA1 mutation carriers [2018–2022].
Online:
http://purlorg/au-research/grants/nhmrc/1140715 and
https://researchdata.ands.org.au/brca-p-an-mutation-carriers/1319302 last access: 02.04.2018

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.